T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Scheduling Nab-paclitaxel With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
First-line Therapy in Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2